Prenoxdiazine

The topic of Prenoxdiazine is one that has generated interest and debate over time. Since its origins, Prenoxdiazine has captured the attention of academics, experts, and hobbyists alike. In the following article, we will explore in detail the most relevant aspects of Prenoxdiazine, addressing its importance, evolution and impact in different areas. Through exhaustive analysis, we will seek to provide a comprehensive view of Prenoxdiazine, with the intention of shedding light on its impact on contemporary society. Without a doubt, Prenoxdiazine is a topic that deserves to be thoroughly investigated, and through this article, we aim to do just that.

Prenoxdiazine
Clinical data
Trade namesLibexin
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
  • 1-ethyl]piperidine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC23H27N3O
Molar mass361.489 g·mol−1
3D model (JSmol)
  • n1c(onc1CC(c2ccccc2)c3ccccc3)CCN4CCCCC4
  • InChI=1S/C23H27N3O/c1-4-10-19(11-5-1)21(20-12-6-2-7-13-20)18-22-24-23(27-25-22)14-17-26-15-8-3-9-16-26/h1-2,4-7,10-13,21H,3,8-9,14-18H2 checkY
  • Key:PXZDWASDNFWKSD-UHFFFAOYSA-N checkY
  (verify)

Prenoxdiazine (marketed as Libexin) is a cough suppressant.[1] It acts peripherally by desensitizing the pulmonary stretch receptors. Therefore, there's a reduction of cough impulses originating in the lungs. Prenoxdiazine is indicated in cough of bronchial origin.

References

  1. ^ Csürös L (1989). "Fifteen years of experience on the use of Libexin tablets". Therapia Hungarica. 37 (1): 50–4. PMID 2667194.


Stub icon

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.

Wikious
Boobota
Sagapedia